New heart procedure aims to zap AFib safely
NCT ID NCT06765356
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called the Farapulse system, which uses electrical pulses to treat atrial fibrillation (AFib), a common heart rhythm problem. Researchers will enroll 275 adults with AFib who are already scheduled for a catheter ablation procedure. The goal is to see if the system can safely and effectively restore normal heart rhythm and reduce the need for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Farapulse Catheter System (FARAWAVE catheter and FARASTAR generator)
What this could lead to
If successful, this could provide a safer, more effective way to treat atrial fibrillation and reduce the need for repeat procedures or long-term medication.
What could go wrong
This is a single-arm study without a comparison group, so results may not prove superiority over existing treatments. Risks include procedural complications like bleeding or heart damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arrhythmia Research Group
Jonesboro, Arkansas, 72401, United States
-
Cardiology Associates Medical Group
Ventura, California, 93003, United States
-
Mount Sinai Morningside
New York, New York, 10025, United States
-
Naples Comprehensive Health
Naples, Florida, 34102, United States
-
Ohio Health Research Institute
Columbus, Ohio, 43214, United States
-
Sentara Health Research Center
Virginia Beach, Virginia, 23455, United States
-
The Mount Sinai Hospital
New York, New York, 10029, United States
-
Trident Medical Center
North Charleston, South Carolina, 29406, United States
-
UPMC Pinnacle Hospitals
Harrisburg, Pennsylvania, 17101, United States